Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. The BSA-based method of dose calculation was adopted without adequate investigation of its ...

Implementing a strategy that focuses on dose rounding for chemotherapies can have a 3-fold impact of decreasing drug costs, minimizing drug waste, and improving treatment efficiency. This strategy and ...

Tibsovo comes as an oral tablet. It belongs to a group of drugs called isocitrate dehydrogenase-1 blockers. At this time, Tibsovo is only available in the brand-name form. There are currently no ...